AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Refici, ML Metzger, DW Arulanandam, BP Lennartz, MR Loegering, DJ
Citation: Ml. Refici et al., Fc gamma-receptor signaling augments the LPS-stimulated increase in serum tumor necrosis factor-alpha levels, AM J P-REG, 280(4), 2001, pp. R1037-R1044

Authors: Buchanan, RM Briles, DE Arulanandam, BP Westerink, MAJ Raeder, RH Metzger, DW
Citation: Rm. Buchanan et al., IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines, VACCINE, 19(15-16), 2001, pp. 2020-2028

Authors: Arulanandam, BP Raeder, RH Nedrud, JG Bucher, DJ Le, JH Metzger, DW
Citation: Bp. Arulanandam et al., IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection, J IMMUNOL, 166(1), 2001, pp. 226-231

Authors: Arulanandam, BP Lynch, JM Briles, DE Hollingshead, S Metzger, DW
Citation: Bp. Arulanandam et al., Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity againstStreptococcus pneumoniae infection, INFEC IMMUN, 69(11), 2001, pp. 6718-6724

Authors: Arulanandam, BP Mittler, JN Lee, WT O'Toole, M Metzger, DW
Citation: Bp. Arulanandam et al., Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines, J IMMUNOL, 164(7), 2000, pp. 3698-3704

Authors: Arulanandam, BP Metzger, DW
Citation: Bp. Arulanandam et Dw. Metzger, Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery, VACCINE, 17(3), 1999, pp. 252-260

Authors: Arulanandam, BP O'Toole, M Metzger, DW
Citation: Bp. Arulanandam et al., Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity, J INFEC DIS, 180(4), 1999, pp. 940-949

Authors: Arulanandam, BP Van Cleave, VH Metzger, DW
Citation: Bp. Arulanandam et al., IL-12 is a potent neonatal vaccine adjuvant, EUR J IMMUN, 29(1), 1999, pp. 256-264
Risultati: 1-8 |